List view / Grid view
Filing Includes data from treatment-naïve patients with advanced fibrosis and…
8 May 2014 | By Johnson & Johnson
Filing Includes data from treatment-naïve patients with advanced fibrosis and null responders with all stages of liver fibrosis...
Janssen continues to undertake clinical studies with telaprevir to identify…
1 November 2013 | By Janssen
Janssen continues to undertake clinical studies with telaprevir to identify opportunities to serve specialized and hard-to-treat patients...
"We're excited to add GSK2336805 to our existing portfolio of…
8 October 2013 | By Janssen Pharmaceuticals, Inc
"We're excited to add GSK2336805 to our existing portfolio of direct-acting antivirals (DAAs)...
The EC has approved a new twice daily dosing of…
31 May 2013 | By Daniel J Edelman Ltd
The EC has approved a new twice daily dosing of INCIVO® (telaprevir)...
The U.S. FDA has granted Priority Review to the NDA…
13 May 2013 | By Johnson & Johnson
The U.S. FDA has granted Priority Review to the NDA for simeprevir (TMC435)...
